UBS Call 98 ABL 19.12.2025/ DE000UM6EX33 /
15/11/2024 19:41:11 | Var.+0.040 | Denaro21:56:54 | Lettera21:56:54 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.330EUR | +1.75% | - Quantità in denaro: - |
- Quantità in lettera: - |
ABBOTT LABS | 98.00 - | 19/12/2025 | Call |
GlobeNewswire
06/08
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
GlobeNewswire
06/06
Circana’s 2023 New Product Pacesetters Report Reveals Innovation Is Meeting Consumers in New Moments
GlobeNewswire
09/05
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire
25/03
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer